• Study on the Effectiveness and Safety of Regorafenib for Patients with Resistant Primary Bone Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Neurexan for Improving Sleep in Patients with Short-Term Insomnia

    Not recruiting

    2 1 1
    Investigated diseases:
    Germany

  • Study on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain

  • Study on Preventing Respiratory Issues from RSV Bronchiolitis in Preterm Babies Using Palivizumab

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study Comparing Bortezomib, Melphalan, Prednisone, Lenalidomide, and Daratumumab for Multiple Myeloma in Patients Ineligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain

  • Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Estonia France Germany Hungary +1

  • Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of Tecaginlimab and Pembrolizumab with Radiotherapy for Patients with Metastatic Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

powered by